Clinical Trial
doi: 10.1016/0140-6736(92)93162-g.
The case for clinical trials of tamoxifen for prevention of breast cancer
Affiliations
- PMID: 1359221
- DOI: 10.1016/0140-6736(92)93162-g
Item in Clipboard
Clinical Trial
The case for clinical trials of tamoxifen for prevention of breast cancer
Lancet.
.
No abstract available
Comment in
-
Prevention of breast cancer.Lancet. 1992 Dec 19-26;340(8834-8835):1551. Lancet. 1992. PMID: 1361641 No abstract available.
-
Prevention of breast cancer.Lancet. 1992 Dec 19-26;340(8834-8835):1551-2. Lancet. 1992. PMID: 1361643 No abstract available.
Similar articles
-
Tamoxifen for breast cancer prevention.Proc Soc Exp Biol Med. 1995 Feb;208(2):144-9. doi: 10.3181/00379727-208-43846c. Proc Soc Exp Biol Med. 1995. PMID: 7831346 Review. No abstract available.
-
Tamoxifen for the prevention of breast cancer: no.Important Adv Oncol. 1995:175-85. Important Adv Oncol. 1995. PMID: 7672804 Review.
-
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.J Natl Cancer Inst. 1995 Sep 20;87(18):1359-64. doi: 10.1093/jnci/87.18.1359. J Natl Cancer Inst. 1995. PMID: 7658496
-
Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.J Natl Cancer Inst. 1999 Nov 3;91(21):1891-2. doi: 10.1093/jnci/91.21.1891. J Natl Cancer Inst. 1999. PMID: 10547398 No abstract available.
-
Breast cancer prevention trial will resume.J Natl Cancer Inst. 1994 Jul 6;86(13):961-3. doi: 10.1093/jnci/86.13.961. J Natl Cancer Inst. 1994. PMID: 8007016 No abstract available.
Cited by
-
Tamoxifen as adjuvant therapy in breast cancer. Current status.Drugs. 1993 Nov;46(5):819-33. doi: 10.2165/00003495-199346050-00003. Drugs. 1993. PMID: 7507033 Review.
-
Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.Pharmacoeconomics. 1993 Jul;4(1):40-66. doi: 10.2165/00019053-199304010-00006. Pharmacoeconomics. 1993. PMID: 10146967 Review.
-
Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.Proc Natl Acad Sci U S A. 1995 May 9;92(10):4206-10. doi: 10.1073/pnas.92.10.4206. Proc Natl Acad Sci U S A. 1995. PMID: 7753783 Free PMC article.
-
Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer.Sci Rep. 2016 May 27;6:26627. doi: 10.1038/srep26627. Sci Rep. 2016. PMID: 27230285 Free PMC article. Review.
-
Effects of tamoxifen on endometrial carcinogenesis in mice.Jpn J Cancer Res. 1998 May;89(5):502-9. doi: 10.1111/j.1349-7006.1998.tb03290.x. Jpn J Cancer Res. 1998. PMID: 9685853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
